CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.

Viviana Lora 1 Jean Kanitakis 1, *
* Auteur correspondant
Abstract : BACKGROUND: CDX2 is a gene involved in the regulation of intestinal cell proliferation/differentiation. It is considered specific for enterocytes and has been used for the diagnosis of primary and metastatic colon adenocarcinoma. The aim of this study was to assess the usefulness of CDX2 in the diagnosis of cutaneous metastatic tumors and extramammary Paget's disease. MATERIALS AND METHODS: The immunohistochemical expression of CDX2 was studied in 68 cutaneous metastatic tumors of various origins and 14 specimens of extramammary Paget's disease. RESULTS: CDX2 expression was found in 3/6 metastases of colon adenocarcinoma, 1/1 metastasis of urothelial carcinoma and 1/2 extramammary Paget's disease. CONCLUSION: CDX2 appears to be specific for cutaneous metastases from intestinal and urothelial carcinomas and is a useful diagnostic marker of these tumors. However, its sensitivity is modest, and we advocate its use in conjunction with additional immunohistochemical markers. CDX2 seems useful for the diagnosis of extramammary Paget's disease associated with an underlying colorectal tumor.
Type de document :
Article dans une revue
Anticancer Research, International Institute of Anticancer Research, 2009, 29 (12), pp.5033-7
Liste complète des métadonnées

Littérature citée [19 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00462238
Contributeur : Jean Kanitakis <>
Soumis le : lundi 8 mars 2010 - 23:27:16
Dernière modification le : jeudi 8 février 2018 - 13:58:21
Document(s) archivé(s) le : mercredi 30 novembre 2016 - 15:25:29

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

  • HAL Id : inserm-00462238, version 1
  • PUBMED : 20044613

Collections

HCL | HEH

Citation

Viviana Lora, Jean Kanitakis. CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.. Anticancer Research, International Institute of Anticancer Research, 2009, 29 (12), pp.5033-7. 〈inserm-00462238〉

Partager

Métriques

Consultations de la notice

154